Table 1.
Characteristics of patients with aggressive non-Hodgkin lymphoma by pre-PET-CT steroid treatment
| Characteristics | Steroid-naïve (n = 131) | Steroid-treated (n = 47) | P value |
|---|---|---|---|
| Female sex, n (%) | 55 (41.99%) | 24 (51.1%) | 0.31 |
| Age (years), mean (SD) | 64.63 (16.13) | 63.79 (15.38) | 0.75 |
| Diabetes mellitus, n (%) | 30 (22.9%) | 12 (25.5%) | 0.69 |
| LDH level (U/L), mean (SD) | 881.64 (1996.93) | 2614.81 (11,762.75) | 0.03 |
| Ki67 index (%), mean (SD) | 71.89 (19.68) | 74.5 (20.02) | 0.32 |
| IPI score, n (%) | |||
| 0–1 | 44 (33.59) | 12 (25.3) | |
| 2–3 | 72 (54.96) | 24 (51.07) | |
| 4–5 | 15 (11.45) | 11 (23.44) | 0.12 |
| Mean IPI score (SD) | 2.10 (1.14) | 2.51 (1.37) | 0.07 |
| Stage, n (%) | |||
| 1 | 26 (19.85) | 2 (4.26) | |
| 2 | 19 (14.51) | 11 (23.41) | |
| 3 | 17 (12.98) | 3 (6.38) | |
| 4 | 69 (52.67) | 31 (65.95) | 0.02 |
| Mean stage, n (SD) | 2.98 (1.22) | 3.34 (0.98) | 0.07 |
LDH lactate dehydrogenase, IPI international prognostic index